Headaches during Mounjaro treatment: points to consider

This is the author’s and her family’s personal experience. The source’s 5–10% figure requires further verification; social-media mentions do not establish clinical incidence or causation. Two liters a day, supplements, painkillers and stopping treatment describe personal choices, not general instructions. Discuss symptoms and medication changes with the prescribing clinician.

I had a striking experience while using Mounjaro (tirzepatide). My appetite fell markedly and I lost weight. My husband also tried it and was pleased with his weight change without headaches. For me, however, headache became a problem.

After the first injection, my head hurt for about a day and then improved. After the second, a throbbing headache lasted more than two days. As someone already prone to headaches, I found it difficult to tolerate.

Headache and Mounjaro in the research discussed by the source

I looked for relevant studies. The original post mentions headaches in approximately 5–10% of trial participants and describes a similar frequency in placebo groups. The exact trial reference requires further verification. Similar reported frequencies would not by themselves prove an indirect cause or rule out a medication-related effect.

The source also refers to a 2025 JMIR Infodemiology study analyzing approximately 60,000 Facebook posts. Headache and joint pain were discussed in tirzepatide-related posts. Online mentions are not clinical incidence rates and cannot establish causation. The source also discusses hypoglycemia, dehydration and dizziness alongside headache, but these possibilities need individual assessment.

Considering blood vessels, hormones and other factors

The original post proposes that changes in food and fluid intake might have contributed to my symptoms. It describes stress hormones—including adrenaline, noradrenaline and cortisol—and uses a hose being squeezed and released as an analogy for vascular changes.

That explanation is the author’s interpretation, not an established diagnosis of the headache or a complete model of headache biology. Reduced intake, hydration and glucose are possible assessment topics, not a way to determine the cause without a clinician.

What I tried

• I took protein and vitamin supplements.
• I tried to drink at least two liters of water daily.
• For constipation, I tried probiotics and psyllium supplements and felt an improvement.

Despite this, I used painkillers to cope with the headaches and decided not to take the next week’s injection.

These are personal experiences, not general instructions about fluid intake, supplements, painkillers or stopping treatment. Discuss persistent symptoms and any medication changes with the prescribing clinician.

I experienced appetite and weight changes alongside headaches that I found hard to tolerate, while my husband’s experience was different. A treatment’s effects and adverse experiences can vary. Paying attention to symptoms and seeking individualized advice matters more than assuming one injection resolves every issue.

Reference discussed: Adverse-event discussions about GLP-1 receptor agonists on Facebook, JMIR Infodemiology, 2025. This observational social-media study is not a clinical adverse-event-rate study.